Just Healthcare

Just Healthcare

Share this post

Just Healthcare
Just Healthcare
Phototherapy Enhances Ritlecitinib Outcomes in Vitiligo Treatment
Copy link
Facebook
Email
Notes
More

Phototherapy Enhances Ritlecitinib Outcomes in Vitiligo Treatment

New phase 2b data shows improved repigmentation with combined light and oral therapy

Naveen Sankar S's avatar
Naveen Sankar S
Apr 22, 2025
∙ Paid

Share this post

Just Healthcare
Just Healthcare
Phototherapy Enhances Ritlecitinib Outcomes in Vitiligo Treatment
Copy link
Facebook
Email
Notes
More
Share
Generated image

Topline


Adding narrowband UVB phototherapy to oral ritlecitinib led to significantly greater repigmentation in patients with nonsegmental vitiligo, with no new safety concerns and improved patient satisfaction, according to a phase IIb extension study.

Study Details

Vitiligo is an autoimmune skin disorder causing depigmented patches due to melanocyte destr…

Keep reading with a 7-day free trial

Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Just Healthcare
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More